Agency Forms Undergoing Paperwork Reduction Act Review, 1492-1493 [2025-00161]
Download as PDF
<![CDATA[
1492
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–25–1046]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Breast and Cervical Cancer Early
Detection Program (NBCCEDP)
Monitoring Activities’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October 1,
2024 to obtain comments from the
public and affected agencies. CDC
received five non-substantive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
VerDate Sep<11>2014
17:50 Jan 07, 2025
Jkt 265001
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
Monitoring Activities (OMB Control No.
0920–1046, Exp. 3/31/2025)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a Revision of the
information collection (OMB Control
No. 0920–1046), titled National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) Monitoring
Activities. Information collection
consists of an annual NBCCEDP survey,
baseline and annual clinic-level data
collection, a quarterly program update
(QPU) tool, a service delivery projection
worksheet, and minimum data elements
(MDEs). CDC proposes revisions to the
Annual NBCCEDP Survey, clinic-level
data collection tool and quarterly
program update (QPU), and continued
use of the service delivery projection
worksheet and MDEs with no changes.
The number of respondents will
increase from 70 to 71 and the total
estimated annualized burden will
decrease from 1,220 hours to 1,162
hours.
Breast and cervical cancers are
prevalent among U.S. women. Evidence
shows that deaths from both breast and
cervical cancers can be avoided by
increasing screening services—
mammography, pap, and human
papillomavirus (HPV) tests—among
women. However, screening is typically
underutilized among women who are
under- or uninsured, have no regular
source of healthcare, or who recently
immigrated to the U.S.
To improve access to cancer
screening, Congress passed the Breast
and Cervical Cancer Mortality
Prevention Act of 1990 (Pub. L. 106–
354), which directed CDC to create the
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP).
The NBCCEDP currently provides
funding to 71 recipients under ‘‘Cancer
Prevention and Control Programs for
State, Territorial, and Tribal
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Organizations (DP22–2202).’’ The
purpose of NBCCEDP is to increase
breast and cervical cancer screening
rates among women residing within
defined geographical locations (as
determined by the funded program) who
are at or below 250% of the federal
poverty level; aged 50–75 years for
breast cancer services, and aged 21–64
years for cervical cancer services; and
are runder- or uninsured.
CDC proposes revisions to three of the
five information collections:
• Annual NBCCEDP Survey—
submitted to CDC annually and collects
program-level information to monitor
recipients’ challenges, external funding
sources, partnerships, and EBI
implementation. The survey has been
revised to add questions related to
partnership activities and recipients’
requirements for patients’ payments
towards screening services, and remove
COVID–19-related questions.
• Clinic-level data collection—
submitted to CDC at baseline and
annually to assess health system, clinic,
and patient population characteristics;
monitoring and quality improvement
activities; EBI implementation; and
baseline or annual screening rates. The
tool has been revised to remove COVID–
19-related variables and update
response options for measures used to
report breast and cervical cancer
screening rates.
• QPU—submitted to CDC four times
per year to monitor award spending,
service delivery, staff vacancies,
program challenges and successes, and
technical assistance (TA) needs. This
instrument has been revised to include
two optional open-ended items for
recipients to provide context to reported
service delivery and spending data if
needed.
CDC proposes continued use of the
remaining two information collections—
the Service Delivery Project Worksheet
and the MDEs—which have not been
changed.
To maximize consistency in our
routine data collections for the current
NBCCEDP funding cycle, CDC has not
revised NBCCEDP information
collections to align with the Department
of Health and Human Services (HHS)’
current best practices for demographic
questions related to sexual orientation
and gender identity (SOGI) and race and
ethnicity (R/E) at this time. However,
CDC plans to revise information
collections that include demographic
items to align with HHS’ SOGI and R/
E guidelines for the next funding cycle
beginning in 2027. The proposed
modifications to the information
collections will allow CDC to better
E:\FR\FM\08JAN1.SGM
08JAN1
1493
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices
gauge progress in meeting NBCCEDP
program goals and monitor
implementation activities, evaluate
outcomes, and identify awardee
technical assistance needs. In addition,
findings will inform program
improvement and help identify
successful activities that need to be
maintained, replicated, or expanded.
CDC requests OMB approval for three
years and for an estimated 1,162 annual
burden hours. Participation is required
for NBCCEDP awardees. There are no
costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
NBCCEDP Recipients .....................................
Annual NBCCEDP Survey .............................
NBCCEDP Clinic-level Information Collection
Instrument—Breast.
NBCCEDP Clinic-level Information Collection
Instrument—Cervical.
Quarterly Program Update .............................
Service Delivery Projection Worksheet ..........
MDEs ..............................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–00161 Filed 1–7–25; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–25CH; Docket No. CDC–2024–
0102]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Combating
Antimicrobial Resistant Gonorrhea and
Other STIs (CARGOS). CARGOS is a
comprehensive strategy designed to
streamline and improve the
coordination of Antimicrobial
Resistance (AR) surveillance and
preparedness and response activities
focused on Neisseria gonorrhoeae (GC)
and expand capacity to include other
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
VerDate Sep<11>2014
17:50 Jan 07, 2025
Jkt 265001
STIs with emerging AR in the United
States.
CDC must receive written
comments on or before March 10, 2025.
ADDRESSES: You may submit comments
identified by Docket No. CDC–2024–
0102 by either of the following methods:
b Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
b Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov. Please note:
Submit all comments through the
Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
DATES:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs)
71
71
1
6
46/60
40/60
71
6
40/60
71
71
71
4
1
2
32/60
29/60
150/60
information, including each new
proposed collection, each proposed
extension of the existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of collecting
information on those to respond,
including using appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic responses;
and
5. Assess information collection costs.
Proposed Project
Combating Antimicrobial Resistant
Gonorrhea and Other STIs (CARGOS)—
New—National Center for HIV, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of the proposed
Combating Antimicrobial Resistant
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 90, Number 5 (Wednesday, January 8, 2025)]
[Notices]
[Pages 1492-1493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00161]
[[Page 1492]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-1046]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Monitoring Activities'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on October 1, 2024 to obtain comments from the
public and affected agencies. CDC received five non-substantive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046, Exp. 3/31/
2025)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the information collection (OMB
Control No. 0920-1046), titled National Breast and Cervical Cancer
Early Detection Program (NBCCEDP) Monitoring Activities. Information
collection consists of an annual NBCCEDP survey, baseline and annual
clinic-level data collection, a quarterly program update (QPU) tool, a
service delivery projection worksheet, and minimum data elements
(MDEs). CDC proposes revisions to the Annual NBCCEDP Survey, clinic-
level data collection tool and quarterly program update (QPU), and
continued use of the service delivery projection worksheet and MDEs
with no changes. The number of respondents will increase from 70 to 71
and the total estimated annualized burden will decrease from 1,220
hours to 1,162 hours.
Breast and cervical cancers are prevalent among U.S. women.
Evidence shows that deaths from both breast and cervical cancers can be
avoided by increasing screening services--mammography, pap, and human
papillomavirus (HPV) tests--among women. However, screening is
typically underutilized among women who are under- or uninsured, have
no regular source of healthcare, or who recently immigrated to the U.S.
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354),
which directed CDC to create the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP). The NBCCEDP currently provides
funding to 71 recipients under ``Cancer Prevention and Control Programs
for State, Territorial, and Tribal Organizations (DP22-2202).'' The
purpose of NBCCEDP is to increase breast and cervical cancer screening
rates among women residing within defined geographical locations (as
determined by the funded program) who are at or below 250% of the
federal poverty level; aged 50-75 years for breast cancer services, and
aged 21-64 years for cervical cancer services; and are runder- or
uninsured.
CDC proposes revisions to three of the five information
collections:
Annual NBCCEDP Survey--submitted to CDC annually and
collects program-level information to monitor recipients' challenges,
external funding sources, partnerships, and EBI implementation. The
survey has been revised to add questions related to partnership
activities and recipients' requirements for patients' payments towards
screening services, and remove COVID-19-related questions.
Clinic-level data collection--submitted to CDC at baseline
and annually to assess health system, clinic, and patient population
characteristics; monitoring and quality improvement activities; EBI
implementation; and baseline or annual screening rates. The tool has
been revised to remove COVID-19-related variables and update response
options for measures used to report breast and cervical cancer
screening rates.
QPU--submitted to CDC four times per year to monitor award
spending, service delivery, staff vacancies, program challenges and
successes, and technical assistance (TA) needs. This instrument has
been revised to include two optional open-ended items for recipients to
provide context to reported service delivery and spending data if
needed.
CDC proposes continued use of the remaining two information
collections--the Service Delivery Project Worksheet and the MDEs--which
have not been changed.
To maximize consistency in our routine data collections for the
current NBCCEDP funding cycle, CDC has not revised NBCCEDP information
collections to align with the Department of Health and Human Services
(HHS)' current best practices for demographic questions related to
sexual orientation and gender identity (SOGI) and race and ethnicity
(R/E) at this time. However, CDC plans to revise information
collections that include demographic items to align with HHS' SOGI and
R/E guidelines for the next funding cycle beginning in 2027. The
proposed modifications to the information collections will allow CDC to
better
[[Page 1493]]
gauge progress in meeting NBCCEDP program goals and monitor
implementation activities, evaluate outcomes, and identify awardee
technical assistance needs. In addition, findings will inform program
improvement and help identify successful activities that need to be
maintained, replicated, or expanded.
CDC requests OMB approval for three years and for an estimated
1,162 annual burden hours. Participation is required for NBCCEDP
awardees. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Recipients.................... Annual NBCCEDP Survey... 71 1 46/60
NBCCEDP Clinic-level 71 6 40/60
Information Collection
Instrument--Breast.
NBCCEDP Clinic-level 71 6 40/60
Information Collection
Instrument--Cervical.
Quarterly Program Update 71 4 32/60
Service Delivery 71 1 29/60
Projection Worksheet.
MDEs.................... 71 2 150/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-00161 Filed 1-7-25; 8:45 am]
BILLING CODE 4163-18-P
